Endothelin-3 (ET-3) stimulated phosphoinositide metabolism and synthesis of prostaglandins in cultured rat Kupffer cells. ET-3-induced hydrolysis of phosphoinositides was characterized by the production of various inositol phosphates and of glycerophosphoinositol. The mechanism of ET-3-stimulated metabolism of phosphoinositides and synthesis of prostaglandins appeared to be distinct from the effect of platelet-activating factor (PAF) on these processes described previously [Gandhi, Hanahan & Olson (1990) J. Biol. Chem. 265, 18234-18241]. On a molar basis ET-3 was significantly more potent than PAF in stimulating phosphoinositide metabolism, e.g. ET-3-induced hydrolysis of phosphoinositides occurred at 1 pM, whereas PAF was ineffective at concentrations less than 1 nm. Upon challenging Kupffer cells with both ET-3 and PAF, an additive stimulation of phosphoinositide metabolism was observed, suggesting that the actions of these factors may be exerted on separate phosphoinositide pools. Treatment of Kupffer cells with pertussis toxin resulted in an inhibition of ET-3-induced phospholipase C activation; in contrast, cholera toxin treatment caused potentiation of ET-3-stimulated phospholipase C activity. Both toxins, however, inhibited PAF-stimulated phospholipase C activity. The present results suggest that the stimulatory effects of ET-3 and PAF on the phosphodiesteric metabolism of phosphoinositides in Kupffer cells require different guanine-nucleotide-binding proteins. Furthermore, the effects of bacterial toxins on ET-3-and PAF-induced phosphoinositide metabolism were not mediated by cyclic AMP. ET-3-induced metabolism of phosphoinositides was inhibited completely in Kupffer cells pretreated with ET-3, suggesting homologous ligand-induced desensitization of the ET-3 receptors. In contrast, similar experiments using PAF showed only a partial desensitization of subsequent PAF-induced phosphoinositide metabolism. In contrast to the increased production of prostaglandins E2 and D2 observed upon stimulation of Kupffer cells with PAF, ET-3 stimulated the biosynthesis of prostaglandin E2 only. Consistent with their additive effects on phosphoinositide metabolism, PAF and ET-3 exhibited an additive stimulation of the synthesis of prostaglandin E2.
INTRODUCTION
Several mediators [e.g. eicosanoids and platelet-activating factor (PAF)] and various cytokines are synthesized by the liver in response to various types of stimulation. These mediators are synthesized primarily by endothelial and Kupffer cells, which reside in the hepatic sinusoids (Jones & Summerfield, 1988) . Kupffer cells, the resident macrophages of the liver, detoxify endotoxin and phagocytose invading microbes, virus particles and senescent erythrocytes and platelets (Jones & Summerfield, 1988) . Various hepatic metabolic events, including biosynthesis of mediators which accompany reticuloendothelial cell activation, are initiated following and hence are regulated by the phosphoinositide signalling cascade.
Endothelin (ET), a potent vasoactive peptide (Yanagisawa et al., 1988; Simonson & Dunn, 1990a) and PAF (Snyder, 1982; Vargaftig et al., 1982) , an etherphospholipid autacoid, exhibit profound mediator effects in a variety of tissues. Both ET (Gandhi et al., 1990a) and PAF (Buxton et al., 1984) are potent agonists in the liver, stimulating glycogenolysis as well as causing alterations in oxygen consumption and vasoconstriction of the hepatic vasculature when infused into the perfused rat liver. A significant amount of ETlike immunoreactivity has been detected in the liver (Yoshimi et al., 1989) , and perfused rat liver challenged with bacterial endotoxin has been found to synthesize several lipid autacoid mediators, including PAF (Duffy-Krywicki et al., 1990) . Also, endotoxin has been reported to cause increased release of ET into the circulation (Sugiura et al., 1989) . Furthermore, the endothelium releases contractile factors in response to anoxic conditions (De Mey & Vanhoutte, 1983; Vanhoutte & Katusis, 1988) . Since liver receives nearly 80 % of its blood supply from the portal vein, this organ is normally exposed to a somewhat hypoxic environment. Because the liver plays a crucial role in the detoxification of endotoxin, it might be conjectured that during conditions such as endotoxaemia, PAF and ET may play significant roles in intercellular signalling mechanisms in the hepatic responses to shock.
We have characterized PAF-mediated signalling events in cultured hepatic Kupffer cells (Gandhi et al., 1990b; Gandhi & Olson, 1991) . Bronchopulmonary effects of ET have been suggested to occur via PAF (Lagente et al., 1989) , and this lipid autacoid has also been implicated in ET-induced mortality of animals (Terashita et al., 1989) . Therefore it was of interest to characterize intra-and inter-cellular signalling systems in which these two autacoid mediators are involved. tussis toxin, cholera toxin, EGTA, phorbol 12-myristate 13-acetate and heat-inactivated fetal bovine serum were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. Synthetic PAF (l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) was obtained from Bachem, Bubendorf, Switzerland, and metrizamide [2-(3-acetamido-5-N-methylacetamido-2,4,6-tri- iodobenzamido)-2-deoxy-D-glucoseI was from Nyegaard and Co., Oslo, Norway. myo-[2-3H]Inositol (20 Ci/mmol) and [5,6,8,9,11,12,14,15-3H] (200-250 g ) using a modification of the centrifugal elutriation procedure of Knook & Sleyster (1976) . Briefly, livers were perfused aseptically for 10 min at 37 'C via the portal vein and with perfusate collection via the inferior vena cava at a rate of 30 ml/min. The medium used for this perfusion was calciumand magnesium-free Krebs-Henseleit buffer containing 0.20% glucose and 0.20 BSA, gassed with 02/C02 (19: 1). This initial perfusion interval was followed by a period of 5 min of recirculating perfusion with the same buffer containing 0.030% collagenase and 0.020% protease in the presence of 2 mM-Ca2l.
Following digestion of the liver the perfusion was stopped, the liver capsule was opened and the cells were dispersed in KrebsHenseleit buffer. The cell suspension was filtered through two layers of nylon mesh and the filtrate was centrifuged at 525 g for 45 s, followed by centrifugation of the supernatant at 830 g for 6 min. The pellet was suspended in Gey's balanced salt solution (GBSS) without NaCl containing 17.50% metrizamide. GBSS (1 ml) was layered over 6 ml of the above cell suspension and, after centrifugation for 20 min at 1400 g, non-parenchymal cells which collected at the interphase were aspirated and washed with Krebs-Henseleit buffer. Kupffer cells and endothelial cells were separated by centrifugal elutriation as described (Knook & Sleyster, 1976 (Powell, 1982) or with ice-cold 5 % trichloroacetic acid after rapidly aspirating the medium for the analysis of inositol phosphates.
Extraction of eicosanoids
Eicosanoids were extracted essentially as described by Powell (1982) . Cells were scraped from the culture plates and both the medium and cells were transferred quantitatively to tubes. The plates were washed with an additional I ml of ethanol and water was added to the combined extracts to bring the final concentration of ethanol to 15 %. The extract was centrifuged and the pellet was washed with 3-4 ml of 15 % ethanol. (Marsden et al., 1989; Takuwa et al., 1989a,b; Kuraja & Woodcock, 1990; Resink et al., 1990; Lin et at., 1990; Vigne et al., 1990) . Fig. 1 illustrates the effects of increasing concentrations of ET-3 on phosphoinositide metabolism via both phospholipase C and deacylation in primary cultures of rat Kupffer cells. Significant stimulation of phosphoinositide metabolism by ET-3 occurred at concentrations as low as 1 pM. It should be noted that several Ca2+-mobilizing glycogenolytic agents which stimulate phosphoinositide metabolism in isolated hepatocytes (Williamson et al., 1985; Williamson, 1986) are not capable of stimulating phospholipase C action in Kupffer cells (Gandhi & Olson, 1991 existence of two separate phases of ET-3-induced phosphoinositide metabolism. It is known that various inositol phosphates accumulate due to the inhibition ofinositol phosphate(s) phosphatases when Li' is added to the incubation medium (Storey et al., 1984; Burges et al., 1985; Hansen et al., 1986; Turk et al., 1986) . In the present study, Li (Jones & Summerfield, 1988) . ET has been shown to stimulate the synthesis of PGs in various cell types (De Nucci et al., 1988; Reynolds et al., 1989; Resink et al., 1989; Simonson & Dunn, 1990b) . Fig. 3 Differential effects of cholera toxin on the ET-3-and PAF-induced metabolism of phosphoinositides Many receptor-mediated transmembrane signalling events, including the metabolism of phosphoinositides, occur via the activation of guanine-nucleotide-binding proteins (G-proteins) (Gilman, 1987) , and these processes are frequently sensitive to cholera toxin and pertussis toxin (Gilman, 1987; Williamson, 1986) . We have reported differential effects of cholera toxin on PAF-induced deacylation and phosphodiesteric hydrolysis of phosphoinositides in Kupffer cells, although pertussis toxin inhibited both of these processes (Gandhi et al., 1990b) . The results illustrated in Fig. 2 suggest that PAF-and ET-3-induced signal transduction may be coupled via different G-proteins. To evaluate the role of G-protein coupling in ET-induced phosphoinositide metabolism, Kupffer cells were first incubated with cholera toxin or pertussis toxin and then were challenged with ET-3. As illustrated in Fig. 4(a) and 4(b) , pertussis toxin inhibited ET-3-induced phosphoinositide metabolism, both at an early time point (i.e. 15 s, extracellular-Ca2+-independent) and after 20 min (extracellular-Ca2+-dependent), consistent with the effect of pertussis toxin on these processes when PAF was employed as the agonist (Gandhi et al., 1990b) . In contrast, cholera toxin potentiated the ET-3-stimulated production of inositol phosphate(s) at both 15 s and 20 min (Fig. 4) . In our previous study, it was demonstrated that PAF-mediated phosphodiesteric hydrolysis of phosphoinositides in Kupffer cells was inhibited by cholera toxin (Gandhi et al., 1990b) . Also, a cholera toxininduced increase in the production of GPIns in Kupffer cells was apparent (Gandhi et al., 1990b) . As shown in Fig. 4(b) , addition of ET-3 to cholera toxin-treated cells caused an increase in GPIns release greater than that observed with ET-3 alone, suggesting that this toxin had no effect on the deacylation process stimulated by Effect of cyclic AMP on the ET-3-and PAF-induced metabolism of phosphoinositides Metabolic events in a cell in response to various agents are of three experiments. *P < 0.02, **P < 0.001 compared with control; tP < 0.05, ttP < 0.02 and tttP < 0.01 respectively compared with ET-3. exerted via the production of intracellular second messengers; it is likely that such second messengers influence complex cellular metabolic events by interacting with different signal transduction mechanisms elicited by the individual agonists. Cholera toxin and pertussis toxin are known to interact with the G-proteins coupled to adenylate cyclase in many cells, elevating cellular cyclic AMP levels (Gilman, 1987) . Therefore it was important to ascertain whether cholera toxin and pertussis toxin stimulate cyclic AMP synthesis in Kupffer cells and thus exert their effects on ET-and PAF-induced phosphoinositide metabolism via this second messenger. The results of these experiments are depicted in Table 2 and Fig. 5 . In cells incubated with dibutyryl cyclic AMP as well as with forskolin, an agent which stimulates cyclic AMP synthesis (Table 2) , both ET-3-and PAF-induced phosphodiesteric hydrolysis ofphosphoinositides was strongly attenuated. In contrast, production of GPIns stimulated by either of these agonists was not affected by cyclic AMP treatment or by forskolin (Fig. 5) . Cholera toxin, which potentiated ET-3-induced phospholipase C activity, caused an increase in cyclic AMP levels in Kupffer cells (Table 2) , whereas pertussis toxin did not alter cyclic AMP levels but strongly inhibited phospholipase C activity. Furthermore, cholera toxin caused significant increase in cyclic AMP levels in the presence of the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX). Neither ET-3 nor PAF elicited any significant change in the cyclic AMP levels in Kupffer cells (Table 2) .
Effects of PAF-and ET-3-mediated desensitization of the phosphoinositide signalling response
Experiments were designed to ascertain whether the actions of PAF and ET-3 on the hydrolysis of phosphoinositides in Kupffer cells were independent of each other. The data shown in Fig. 6 indicate that preincubation of Kupffer cells with either agonist had no effect on the metabolism of phosphoinositides induced by the other agonist. These results are consistent with the observations reported previously that PAF did not affect glycogenolysis, oxygen consumption or vasoconstriction of the hepatic vasculature induced by ET-3, or vice versa, in the isolated perfused rat liver (Gandhi et al., 1990a) .
Effects of preincubation with ET-3 or PAF on subsequent stimulation of phosphoinositide metabolism with homologous ligand Repeated bolus infusion of ET-3 into the perfused rat liver resulted in a diminished glycogenolytic response but had little effect on the usual vasoconstrictive response to ET-3 (Gandhi et al., 1990a) . Also, it has been demonstrated that PAF-induced hepatic responses can be desensitized to subsequent PAF challenges (Buxton et al., 1984) . Therefore it was of interest to determine how Kupffer cells exposed to PAF or ET-3 respond to a subsequent challenge with the same agonist. Kupffer cells in primary culture labelled with [3H]inositol were washed and then incubated with ET-3 or PAF for 3 h. Following this treatment, the cells were washed extensively and challenged with the same agonist. It is evident from Fig. 7(a) that preincubation of Kupffer cells with ET-3 produced a strong attenuation of a subsequent ET-3-induced hydrolysis of phosphoinositides, suggesting some type of desensitization or regulation of ET-3 receptors. Preincubation of Kupffer cells with PAF partially desensitized the subsequent PAF-induced metabolism of phosphoinositides (Fig.   7b ).
DISCUSSION
The present investigation describes similarities and differences between the effects of ET and PAF on phosphoinositide metabolism and PG synthesis in cultured Kupffer cells. Like PAF of duplicate determinations from a representative experiment. *P < 0.05, **P < 0.02, ***P < 0.01; tP < 0.005, ttP < 0.001 compared with control. (Gandhi et al., 1990b) , ET-3 stimulated phosphodiesteric hydrolysis as well as deacylation of phosphoinositides in cultured Kupffer cells. On a molar basis ET-3 was more potent in eliciting these responses (Fig. 1) than PAF (Gandhi et al., 1990b) . Although both PAF (Buxton et al., 1984) and ET-3 (Gandhi et al., 1990a) exert glycogenolytic effects in the perfused liver, it should be noted that ET-3 (Serradeil-Le Gal et al., 1991) but not PAF stimulates conversion of glycogen phosphorylase from its inactive into its active form in isolated hepatocytes. Furthermore, ET-3 stimulates phospholipase Cand phospholipase A2-mediated phosphoinositide metabolism in isolated hepatocytes (Gandhi et al., 1990a) , whereas PAFinduced metabolism of phosphoinositides occurs via phospholipase A2 only (Shukla et al., 1983; Gandhi & Olson, 1991) . Hence, in certain respects, ET may be a more versatile agonist in the liver than PAF.
One of the functional responses that Kupffer cells exhibit to a variety of stimuli is the production of eicosanoids (Dieter et al., 1986; Jones and Summerfield, 1988) . In contrast to PAF, which stimulates the synthesis of both PGD2 and PGE2 in cultured Kupffer cells prelabelled with [3H]arachidonic acid (Gandhi et al., 1989; Gandhi & Olson, 1991) , ET-3 specifically stimulated the biosynthesis of PGE2 but not of PGD2 (Fig. 3) . Moreover, incubation of Kupffer cells with both ET-3 and PAF resulted in an additive stimulation of PGE2 synthesis, whereas PGD2 synthesis was not stimulated over that with PAF alone (Fig. 3) .
These results are analogous to the additive effects of PAF and ET-3 on phosphoinositide metabolism in the Kupffer cell (Fig.  2) . Thus the additive effects of these two agonists on the Kupffer cell infer that PAF and ET-3 act independently of each other in eliciting phosphoinositide metabolism and synthesis of eicosanoids. The effect of ET-3 on the selective stimulation of PGE2 synthesis and an additive stimulation of PGE2 synthesis by ET-3 and PAF in Kupffer cells is interesting. Although a definitive role for PGs in the liver has not been precisely defined, PGE2 has been implicated as a mitogenic agent in cultured hepatocytes (Andreis et al., 1981; Spolarics et al., 1984) and as a vasodilator (Samuelsson et al., 1978) .
The results in Fig. 2 suggest that ET-3 and PAF stimulate phosphoinositide metabolism via different G-proteins. Consistent with the effect of pertussis toxin on PAF-mediated phosphoinositide metabolism (Gandhi et al., 1990b) , ET-3-induced phosphoinositide metabolism also was inhibited by this toxin (Fig. 4) . Considering the inability of pertussis toxin to alter A23187-stimulated hydrolysis of phosphoinositides (Gandhi et al., 1990b) , it would appear that PAF-and ET-3-induced signal transduction occurs via a common pertussis toxin-sensitive G-protein. Interestingly, ET-induced metabolism of phosphoinositides in vascular smooth muscle cells has been reported to be pertussis toxininsensitive (Takuwa et al., 1990) , indicating variability in the pertussis toxin-sensitive G-protein coupled to ET receptors in different cell types. In contrast to the effect of pertussis toxin, treatment of Kupffer cells with cholera toxin resulted in potentiation of ET-3-induced phosphodiesteric hydrolysis of phosphoinositides (Fig. 4) . This observation differs from the inhibitory effect of this toxin on PAF-mediated phospholipase C activation (Gandhi et al., 1990b) . Thus a cholera toxin-sensitive G-protein coupled to the ET-3 receptor is complementary to the action of ET, but appears to be distinct from the PAF-receptor-coupled G-protein.
Cholera toxin and pertussis toxin are known to elevate cellular cyclic AMP levels by interacting with G-proteins coupled to adenylate cyclase (Gilman, 1987) . Hence it was important to determine whether these toxins are capable of influencing PAFinduced (Gandhi et al., 1990b; Gandhi & Olson, 1991) and ET-3-induced phosphoinositide metabolism via an elevation of cellular cyclic AMP levels. Cholera toxin treatment produced an increase in cyclic AMP in Kupffer cells, whereas pertussis toxin had no such effect (Table 2) . Furthermore, dibutyryl cyclic AMP and forskolin, an activator of adenylate cyclase (Seamon & Daly, 1981) (Table 2) , inhibited both ET-3 and PAF-induced phospholipase C activity (Fig. 5) .
Interestingly, neither cholera toxin treatment nor preincubation of Kupffer cells with dibutyryl cyclic AMP or forskolin inhibited ET-3-or PAF-induced GPIns formation (Fig. 5 ; see also Gandhi et al., 1990b) . It should be noted that, in the absence of IBMX, a significant increase in the cyclic AMP levels following incubation of cells with cholera toxin did not occur (Table 2) . These results indicate that the effects of cholera toxin on PAFand ET-3-induced phosphoinositide metabolism in Kupffer cells were not mediated via cyclic AMP. Further, these experiments support our suggestion that different G-proteins are involved in the regulation of the signal transduction events induced by ET and PAF.
Desenitization of the ET-3-induced glycogenolytic response in the perfused rat liver occurred when this organ was subjected to successive infusions; however, hepatic vasoconstriction induced by ET-3 was not affected under these conditions (Gandhi et al., 1990a) . In contrast, homologous desensitization of PAFinduced hepatic glycogenolysis as well as vasoconstriction has been described (Buxton et al., 1984) . Interestingly, neither PAF nor ET-3 altered vasoconstriction, glucose production or oxygen consumption induced by the other agonist in the perfused rat liver (Gandhi et al., 1990a) . Consistent with this observation, preincubation of Kupffer cells with either agonist did not affect phosphoinositide metabolism induced subsequently by the other agonist (Fig. 6) . Preincubation of Kupffer cells with ET-3 resulted in complete attenuation of the metabolism of phosphoinositides when the cells were challenged subsequently with the homologous agonist (Fig. 7a) . In view of the decreased 125I-endothelin binding to its receptors observed following exposure to ET in C-6 cells (Cozza et al., 1990) , cardiomyocytes and hepatocytes (C. R. Gandhi, R. Behal, S. A. K. Harvey, T. A. Nouchi & M. S. Olson, unpublished work), the results described in Fig. 7(a) suggest that receptors for ET-3, coupled to transmembrane signalling via phosphoinositides in the Kupffer cell, were desensitized or possibly down-regulated, although definitive proof of the latter suggestion is not available at the present time. A similar experiment with PAF showed incomplete attenuation of subsequent PAF-induced phosphoinositide metabolism (Fig.  7a) , suggesting partial desensitization or down-regulation of PAF receptors (Chao et al., 1989) . Alternatively, the possibility of PAF effects on phosphoinositide metabolism being mediated through some type of intracellular action (Marcheselli et al., 1990 ) cannot be ruled out.
Administration of radiolabelled ET to rats followed by localization of the labelled peptide in various tissues indicated that a significant portion of the administered ET was found in the liver (Anggard et al., 1989; Koseki et al., 1989; Shiba et al., 1989) , suggesting that the liver may be a major site of ET action and/or metabolism. Under conditions such as hypoxia, and in response to endotoxin and thrombin, the endothelium synthesizes contractile factor(s), presumably ET (De Mey & Vanhoutte, 1982 Vanhoutte & Katusis, 1988; Sugiura et al., 1989; Moon et al., 1989) . Such conditions are also known to enhance the synthesis of PAF in the liver (D. S. Lapointe & M. S. Olson, unpublished work; Duffy-Krywicki et al., 1990) . Physiologically, the liver is exposed to a somewhat hypoxic environment, since it receives nearly 80 % of its blood supply from the portal vein. The liver, and specifically the Kupffer cell, plays a significant role in the detoxification of endotoxin from circulating blood (Jones & Summerfield, 1988) . It would follow that during various types of trauma, tissue injury, endotoxaemia and hypoxia, increased hepatic synthesis of PAF and/or ET occurs. Thus, under certain conditions, in view of the independent effects of PAF and ET on Kupffer cells, parenchymal cells and intact liver, these two autacoids may play significant roles in hepatic pathophysiology. This work was supported by grants from the NIH (DK-19473) and the Robert A. Welch Foundation (AQ-728). K. S. received a predoctoral fellowship from Berlex Laboratories, Inc.
